Metin Kurtoglu, the Chief Technology Officer of $RNAC ($RNAC), sold 32,789 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 39.1% of their shares. Following this trade, they now own 51,033 shares of $RNAC stock.

$RNAC Insider Trading Activity

$RNAC insiders have traded $RNAC stock on the open market 31 times in the past 6 months. Of those trades, 17 have been purchases and 14 have been sales.

Here's a breakdown of recent trading of $RNAC stock by insiders over the last 6 months:

• METIN KURTOGLU (Chief Technology Officer) has traded it 9 times. They made 0 purchases and 9 sales, selling 121,057 shares.
• TIMOTHY A SPRINGER has traded it 16 times. They made 16 purchases, buying 645,677 shares and 0 sales.
• CHRISTOPHER M JEWELL (Chief Scientific Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 52,115 shares.
• MILOS MILJKOVIC (Chief Medical Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 55,000 shares.
• TIMOTHY C BARABE purchased 7,500 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RNAC Hedge Fund Activity

We have seen 35 institutional investors add shares of $RNAC stock to their portfolio, and 45 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 2,341,054 shares (+458.3%) to their portfolio in Q3 2024
• MILLENNIUM MANAGEMENT LLC removed 994,632 shares (-100.0%) from their portfolio in Q2 2024
• CITADEL ADVISORS LLC added 375,767 shares (+inf%) to their portfolio in Q3 2024
• MPM BIOIMPACT LLC added 369,727 shares (+142.4%) to their portfolio in Q3 2024
• CM MANAGEMENT, LLC removed 305,482 shares (-100.0%) from their portfolio in Q2 2024
• ARTAL GROUP S.A. removed 304,554 shares (-100.0%) from their portfolio in Q3 2024
• INVESCO LTD. removed 244,699 shares (-100.0%) from their portfolio in Q2 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.